MiRagen reports loss, effects reverse stock split
BOULDER — miRagen Therapeutics Inc. (Nasdaq: MGEN), a Boulder-based biotechnology company developing new treatments for patients with diseases that are […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
Biotechnology boom
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
Brickell Biotech launches brand reset amid positioning pivot
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI), a clinical-stage pharmaceutical company, has launched a new brand, logo and website as…
Lightning eMotors seeks reverse stock split to remain on NYSE
LOVELAND — In an effort to boost its stock price above $1 and maintain its listing on the New York…
Flatiron Park’s next phase
BOULDER — So, it’s early 2022, COVID-19 is wreaking havoc on the market for office space, and you’ve just made…